ANVISA registration 80146502431Valid until Jul 27, 2036LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER
ANVISA Registration Number: 80146502431ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT IRELAND DIAGNOSTICS DIVISIONRisk Class III
Device names
- Technical name
- LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER
- Risk class
- Class III
Registration details
- Registration Number
- 80146502431
- Process Number
- 25351099645202680
- CNPJ
- 56998701000116
Company information
- Registration Holder
- ABBOTT LABORATORIOS DO BRASIL LTDA
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturing Country
- Ireland
PT: IRLANDA
Dates and status
- Publication Date
- Jul 27, 2026
- Validity
- 27/07/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502431 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Jul 27, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.